REGULUS THERAPEUTICS INC.

Analyst Reco. Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Market Closed - Nasdaq Other stock markets 02:00:00 04/05/2024 am IST			5-day change	1st Jan Change
2.65 ^USD	-1.49%		+9.50%	+107.03%

21/03	Regulus Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
21/03	Regulus Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Canaccord Genuity Trims Price Target on Regulus Therapeutics to $11 From $12, Maintains Buy Rating	19/03	MT
Leerink Partners Initiates Regulus Therapeutics at Outperform Rating With $6 Price Target	18/03	MT
Wells Fargo Adjusts Regulus Therapeutics Price Target to $3 From $2, Maintains Equal Weight Rating	13/03	MT
Canaccord Genuity Raises Regulus Therapeutics' Price Target to $12 From $9, Keeps Buy Rating	21/23/21	MT
HC Wainwright Adjusts Price Target on Regulus Therapeutics to $9 From $20, Maintains Buy Rating	21/23/21	MT
Canaccord Genuity Starts Regulus Therapeutics at Buy With $9 Price Target	08/22/08	MT
Wedbush Adjusts Regulus Therapeutics' Price Target to $0.42 From $1 Following Private Equity Placement; Neutral Rating Kept	21/22/21	MT
REGULUS THERAPEUTICS : Cantor Fitzgerald Reinstates Regulus Therapeutics at Overweight with $2 Price Target	02/21/02	MT
REGULUS THERAPEUTICS : Wedbush Halves Regulus Therapeutics' PT to $1 From $2 on RGLD4326 Timeline for Autosomal Dominant Polycystic Kidney Disease; Neutral Rating Kept	14/21/14	MT
REGULUS THERAPEUTICS : HC Wainwright Adjusts Regulus Therapeutics' Price Target to $2 From $1.50, Maintains Buy Rating	14/21/14	MT
REGULUS THERAPEUTICS : Wedbush Adjusts Price Target on Regulus Therapeutics to $2 From $1, Maintains Neutral Rating	17/21/17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer